Stock AHCO DFB HEALTHCARE ACQUISITIONS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

DFB Healthcare Acquisitions Corp. Stock

Equities

AHCO

US23291E1091

Delayed Nasdaq
Other stock markets
 11:18:46 2021-10-05 EDT 		5-day change 1st Jan Change
23.49 USD -0.29% Intraday chart for DFB Healthcare Acquisitions Corp. -0.88% -37.27%
05-07 AdaptHealth's Shares Fall After Q1 Net Loss Misses Analysts' Forecast MT
05-07 Earnings Flash (AHCO) ADAPTHEALTH Reports Q1 Revenue $792.5M, vs. Street Est of $769.9M MT
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2017 - Sales 2018 - Capitalization 307M 418M
Net income 2017 - 0 Net income 2018 2M 2.72M EV / Sales 2017 * -
Net cash position 2017 25K 34.01K Net cash position 2018 947K 1.29M EV / Sales 2018 -
P/E ratio 2017 *
-
P/E ratio 2018
147 x
Employees -
Yield 2017 *
-
Yield 2018
-
Free-Float 0%
More Fundamentals * Assessed data

Chart DFB Healthcare Acquisitions Corp.

Dynamic Chart

Latest news about DFB Healthcare Acquisitions Corp.

AdaptHealth's Shares Fall After Q1 Net Loss Misses Analysts' Forecast MT
Earnings Flash (AHCO) ADAPTHEALTH Reports Q1 Revenue $792.5M, vs. Street Est of $769.9M MT
AdaptHealth Names Suzanne Foster as CEO MT
UBS Adjusts AdaptHealth Price Target to $13 From $9, Maintains Buy Rating MT
Deutsche Bank Adjusts AdaptHealth Price Target to $10 From $8, Maintains Hold Rating MT
AdaptHealth's Q4 Loss Widens, Revenue Rises; Provides 2024 Revenue Guidance; Shares Climb MT
Earnings Flash (AHCO) ADAPTHEALTH Posts Q4 Revenue $858.2M, vs. Street Est of $825.5M MT
UBS Trims AdaptHealth Price Target to $9 From $10, Maintains Buy Rating MT
UBS Adjusts AdaptHealth Price Target to $10 From $18, Maintains Buy Rating MT
BofA Securities Downgrades AdaptHealth to Underperform From Neutral, Adjusts Price Target to $6.50 From $9.50 MT
AdaptHealth Facing Headwinds Due to Slower-Than-Expected Patient Transitions, BofA Says MT
Deutsche Bank Adjusts AdaptHealth Price Target to $8 From $14, Maintains Hold Rating MT
RBC Cuts Price Target on AdaptHealth to $13 From $18, Keeps Outperform Rating MT
Earnings Flash (AHCO) ADAPTHEALTH Reports Q3 Revenue $804M, vs. Street Est of $796.6M MT
BofA Securities Adjusts AdaptHealth's Price Target to $11 From $13, Keeps Neutral Rating MT
More news

Analyst Recommendations on DFB Healthcare Acquisitions Corp.

UBS Adjusts AdaptHealth Price Target to $13 From $9, Maintains Buy Rating MT
Deutsche Bank Adjusts AdaptHealth Price Target to $10 From $8, Maintains Hold Rating MT
UBS Trims AdaptHealth Price Target to $9 From $10, Maintains Buy Rating MT
UBS Adjusts AdaptHealth Price Target to $10 From $18, Maintains Buy Rating MT
BofA Securities Downgrades AdaptHealth to Underperform From Neutral, Adjusts Price Target to $6.50 From $9.50 MT
More recommendations

Press releases DFB Healthcare Acquisitions Corp.

AdaptHealth Corp. to Participate in the BofA Securities 2024 Health Care Conference BU
AdaptHealth Corp. Announces First Quarter 2024 Results BU
AdaptHealth Corp. Announces First Quarter 2024 Earnings Release Date and Conference Call BU
AdaptHealth Appoints Suzanne Foster as Chief Executive Officer BU
AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook AQ
More press releases

Company Profile

Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. AHCO Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW